Mircera 美血樂注射劑50微公克 | 合法藥品大搜索

ATC7藥理類別, B03XA03 methoxy polyethylene glycol-epoetin beta ... 紅血球生成素（erythropoietin）乃是紅血球發育的主要增生因子，其生成部位為腎臟，並會 ... Read More

由 MP Curran 著作 · 2008 · 被引用 74 次 — Methoxy polyethylene glycol-epoetin beta (Mircera) is a continuous erythropoietin receptor activator, with a long half-life (approximately 130 hours). In patients ... Read More

由 H Schmid 著作 · 2016 · 被引用 5 次 — Methoxy polyethylene glycol-epoetin beta (MPG-EPO), also called continuous erythropoietin receptor activator, is the longest acting ... Read More

商品名稱, Mircera. 內含量, 50mcg/0.3mL/syringe. 學名, Methoxy Polyethylene Glycol-Epoetin Beta. 商品外觀, 外盒黃邊. 健保碼, KC00868248, ATC, B03XA03. Read More

2011年5月19日 — 新藥methoxy polyethylene glycol-epoetin beta是一種長效型紅血球生成刺激素，​又稱為持續性紅血球生成素受體活化劑，每2週或每月注射一次， ... Read More

2015年9月16日 — Methoxy polyethylene glycol-epoetin beta is a chemically synthesised Erythropoiesis Stimulating Agent (ESA) with a longer half-life than ... Read More

Methoxy polyethylene glycol-epoetin beta is the active ingredient of a drug marketed by Hoffmann-La Roche under the brand name Mircera. Mircera is a ... Read More

2021年2月1日 — Methoxy polyethylene glycol-epoetin beta injection is used to treat anemia in adults with chronic kidney disease (CKD) who may or may not be ... Read More

This medication is used to treat anemia (low red blood cell count) in people with long-term serious kidney disease (chronic kidney disease). It works by signaling​ ... Read More

2019年1月15日 — If you receive enough methoxy polyethylene glycol-epoetin beta injection to increase your hemoglobin to a normal or near normal level, there is a ... Read More